Medisafe’s patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.
The first is a computerized locking device that prevents unauthorized medical and drug related products from leaving inventory storage to reduce instances of theft and fraud.
The second is a physical locking device for syringes and capsules that functions differently from the current commercial Medisafe 1 Technologies’ product line.
The third is a physical locking device that measures the release of prescribed dosages, to prevent administration of too much medication.
Medisafe 1 Technologies CEO Jacob Elhadad said the filing of these additional patents demonstrates Medisafe 1 Technologies’ commitment to research and development and to finding the best methods to prevent the unauthorized administration of prescription medications.
